How real-time data could transform clinical trials

About this episode

Iddo Peleg discusses the future of clinical trials and the impact of real-time data amidst global challenges.

In this week’s podcast, we welcome Iddo Peleg, CEO and co-founder of Yonalink, who provides insights into the current and future state of the clinical trial industry. As we move headlong into 2025, a year that appears set to be characterized by global economic and political turmoil, Iddo discusses major trends in the industry, including challenges posed by the COVID-19 aftermath and the potential impacts of regulatory upheaval on clinical trials. He also outlines how Yonalink’s ...

People in this episode

Host: Simon Wentworth

Guest: Iddo Peleg

Topics covered

• clinical trials
• real-time data
• healthcare trends
• COVID-19 impact
• regulatory challenges

Keywords

• clinical trials
• real-time data
• Iddo Peleg
• Yonalink
• COVID-19
• regulatory upheaval
• healthcare

Mentioned in this episode

Organizations: Yonalink

More episodes of The Pharma Letter Podcast

• BenevolentAI CEO on the future of AI-led medicine · May 6, 2026 · 30 min
• ConcertAI CEO Eron Kelly on Big Tech's role in biotech · March 13, 2026 · 18 min
• How blood cancer treatment is evolving in the Middle East · December 8, 2025 · 22 min
• Nouscom bets on dual vaccine strategy to outsmart cancer · July 25, 2025 · 20 min
• Is this a revolution in Alzheimer's? · June 12, 2025 · 21 min
• Why Boehringer and GSK are betting on Ochre · May 23, 2025 · 19 min